Arcutis Biotherapeutics
Presence
Arcutis Biotherapeutics is one of the...
Arcutis Biotherapeutics is a company listed under the stock ticker ARQT (US).
Acquisition, funding and merger involving Arcutis Biotherapeutics.
- Arcutis Biotherapeutics has announced the acquisition of Ducentis BioTherapeutics (posted on September 16 2022).
Executives
View the org chart displaying its 37 main executives
Most searched biographies at Arcutis Biotherapeutics
- Frank Watanabe, Director, President and Chief Executive Officer
- Halley Gilbert, Director
- Howard Welgus, Director
Popular executive movements at Arcutis Biotherapeutics
- David Topper has joined the company as Chief Financial Officer (posted on April 12 2024).
- John Smither, Chief Financial Officer, will leave the company on Apr. 30, 2024 (posted on April 12 2024).
- Todd Tucker, who was Vice President, Human Resources, is promoted to Senior Vice President and Chief Human Resources Officer (posted on March 12 2024).
Click here to view some more movements at Arcutis Biotherapeutics
Create your alert
to follow the executive moves at Arcutis Biotherapeutics.
Biotechnology
Arcutis Biotherapeutics has 2,294 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by Arcutis Biotherapeutics
Social media about Arcutis Biotherapeutics
- Arcutis Biotherapeutics on Wikipedia, Google News & Yahoo Finance
- Arcutis Biotherapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Frank Watanabe 
Call Arcutis Biotherapeutics at +1 805...
